MR arthrography: pharmacology, efficacy and safety in clinical trials
β Scribed by G. Schulte-Altedorneburg; M. Gebhard; W. Wohlgemuth; W. Fischer; J. Zentner; R. Wegener; T. Balzer; K. Bohndorf
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 236 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0364-2348
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract MRI has a wide variety of applications in the clinical trials process. MR has shown particular utility in the early phases of clinical development, when trial sponsors are interested in demonstrating proof of concept and must make decisions about allocation of resources to a particular
## Abstract ## Purpose To assess the safety, effective dose, and efficacy of a novel hepatobiliary MR contrast agent GdβDTPAβDeA for imaging liver tumors, from the clinical phase I and phase II trials in Japan. ## Materials and Methods In a phase I trial, 33 healthy volunteers were intravenously